Literature DB >> 1658608

Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.

D S Ragsdale1, T Scheuer, W A Catterall.   

Abstract

This study examined the actions of phenytoin, carbamazepine, lidocaine, and verapamil on rat brain type IIA Na+ channels functionally expressed in mammalian cells, using the whole-cell voltage-clamp recording technique. The drugs blocked Na+ currents in both a tonic and use-dependent manner. Tonic block was more pronounced at depolarized holding potentials and reduced at hyperpolarized membrane potentials, reflecting an overall negative shift in the relationship between membrane potential and steady state inactivation. Dose-response relationships with phenytoin supported the hypothesis that the voltage dependence of tonic block resulted from the higher affinity of the drugs for inactivated than for resting channels. At -62 mV, approximately 50% of the Na+ channels were blocked by phenytoin at 13 microM, compared with therapeutic brain levels of 4-8 microM. The use-dependent component of block developed progressively during a 2-Hz train of 40-msec-long stimulus pulses from -85 mV to 0 mV. At 2 Hz, verapamil was the most potent use-dependent blocker, lidocaine and phenytoin had intermediate potencies, and carbamazepine was least effective. The use-dependent block resulted from drug binding to open and inactivated channels during the depolarizing pulses and the slow repriming of drug-bound channels during the interpulse intervals. Verapamil, lidocaine, and phenytoin all bound preferentially to open channels, but this open channel block was most striking for verapamil. Use-dependent block was less pronounced at hyperpolarized membrane potentials, due to more rapid repriming of drug-bound channels. The results indicate that type IIA Na+ channels expressed in a mammalian cell line retain the complex pharmacological properties characteristic of native Na+ channels. These channels are likely to be an important site of the anticonvulsant action of phenytoin and carbamazepine. Lidocaine and verapamil, drugs with well characterized effects on peripheral Na+ and Ca2+ channels, are also effective blockers of these brain Na+ channels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658608

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  51 in total

1.  Functional characterization of the pentapeptide QYNAD on rNav1.2 channels and its NMR structure.

Authors:  R Padmashri; K S Chakrabarti; D Sahal; R Mahalakshmi; S P Sarma; S K Sikdar
Journal:  Pflugers Arch       Date:  2003-12-23       Impact factor: 3.657

Review 2.  Voltage-gated sodium channel-associated proteins and alternative mechanisms of inactivation and block.

Authors:  Mitchell Goldfarb
Journal:  Cell Mol Life Sci       Date:  2011-09-27       Impact factor: 9.261

Review 3.  Bacterial voltage-gated sodium channels (BacNa(V)s) from the soil, sea, and salt lakes enlighten molecular mechanisms of electrical signaling and pharmacology in the brain and heart.

Authors:  Jian Payandeh; Daniel L Minor
Journal:  J Mol Biol       Date:  2014-08-23       Impact factor: 5.469

4.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-24

5.  Sidedness of carbamazepine accessibility to voltage-gated sodium channels.

Authors:  Sooyeon Jo; Bruce P Bean
Journal:  Mol Pharmacol       Date:  2013-12-06       Impact factor: 4.436

6.  Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.

Authors:  Ken McCormack; Sonia Santos; Mark L Chapman; Douglas S Krafte; Brian E Marron; Christopher W West; Michael J Krambis; Brett M Antonio; Shannon G Zellmer; David Printzenhoff; Karen M Padilla; Zhixin Lin; P Kay Wagoner; Nigel A Swain; Paul A Stupple; Marcel de Groot; Richard P Butt; Neil A Castle
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

Review 7.  Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

8.  Inhibition of Navβ4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide.

Authors:  Jonathan W Theile; Theodore R Cummins
Journal:  Mol Pharmacol       Date:  2011-07-25       Impact factor: 4.436

Review 9.  Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Authors:  Sarah J Nevitt; Maria Sudell; Jennifer Weston; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2017-06-29

10.  A multi PDZ-domain protein Pdzd2 contributes to functional expression of sensory neuron-specific sodium channel Na(V)1.8.

Authors:  Dongmin Shao; Mark D Baker; Bjarke Abrahamsen; Francois Rugiero; Misbah Malik-Hall; W-Y Louisa Poon; Kathryn S E Cheah; Kwok-Ming Yao; John N Wood; Kenji Okuse
Journal:  Mol Cell Neurosci       Date:  2009-07-14       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.